• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种控制p63/p73稳态的微小RNA依赖性调控通路:p53家族的相互作用带来治疗机遇。

A microRNA-dependent circuit controlling p63/p73 homeostasis: p53 family cross-talk meets therapeutic opportunity.

作者信息

Ory Benjamin, Ellisen Leif W

机构信息

Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA 02114, USA.

出版信息

Oncotarget. 2011 Mar;2(3):259-64. doi: 10.18632/oncotarget.244.

DOI:10.18632/oncotarget.244
PMID:21436470
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3260809/
Abstract

The p53 family transcription factors p53, p63 and p73 make diverse contributions in development and cancer. Mutation or deletion of p53 is observed in the majority of human cancers. In contrast, p63 and p73 are not lost in cancer but mediate distinct genetic roles in normal and tumor-specific contexts: p73 promotes genome stability and mediates chemosensitivity, while p63 largely lacks these p53-like functions and instead promotes proliferation and cell survival. We recently uncovered a mechanism which maintains p63/p73 homeostasis within the epithelium through direct transcriptional regulation of microRNAs (miRs). We discovered that several of the top p63-regulated miRs target p73 for inhibition, including miR-193a-5p, a direct p63/p73 transcriptional target which is repressed by p63 and activated by p73 both in vitro and in vivo. The resulting feed-forward circuit involving p63, miR-193a-5p and p73 controls p73 levels, cell viability and DNA damage susceptibility in certain cancers including squamous cell carcinoma. Here, we discuss the evolutionary implications of this regulatory circuit, which may point to a general mechanism of miR-mediated cross-talk within transcription factor gene families. Additionally, we suggest that inducible chemoresistance mediated by this miR-dependent mechanism might be an attractive target for therapeutic intervention.

摘要

p53家族转录因子p53、p63和p73在发育和癌症中发挥着不同的作用。在大多数人类癌症中都观察到p53的突变或缺失。相比之下,p63和p73在癌症中并未缺失,但在正常和肿瘤特异性环境中介导不同的遗传作用:p73促进基因组稳定性并介导化学敏感性,而p63在很大程度上缺乏这些类似p53的功能,反而促进增殖和细胞存活。我们最近发现了一种机制,该机制通过对微小RNA(miR)的直接转录调控来维持上皮细胞内p63/p73的稳态。我们发现,几个受p63高度调控的miR靶向抑制p73,包括miR-193a-5p,它是p63/p73的直接转录靶点,在体外和体内均受p63抑制并被p73激活。由此产生的涉及p63、miR-193a-5p和p73的前馈回路控制着某些癌症(包括鳞状细胞癌)中的p73水平、细胞活力和DNA损伤易感性。在这里,我们讨论了这种调控回路的进化意义,它可能指向转录因子基因家族内miR介导的相互作用的一般机制。此外,我们认为由这种miR依赖性机制介导的诱导性化疗耐药性可能是治疗干预的一个有吸引力的靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93da/3260809/eb129fc31727/oncotarget-02-259-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93da/3260809/eb129fc31727/oncotarget-02-259-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93da/3260809/eb129fc31727/oncotarget-02-259-g001.jpg

相似文献

1
A microRNA-dependent circuit controlling p63/p73 homeostasis: p53 family cross-talk meets therapeutic opportunity.一种控制p63/p73稳态的微小RNA依赖性调控通路:p53家族的相互作用带来治疗机遇。
Oncotarget. 2011 Mar;2(3):259-64. doi: 10.18632/oncotarget.244.
2
A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinoma.一种 microRNA 依赖的程序控制了人源和鼠源鳞状细胞癌中 p53 非依赖性存活和化疗敏感性。
J Clin Invest. 2011 Feb;121(2):809-20. doi: 10.1172/JCI43897.
3
The tumor suppressors p53, p63, and p73 are regulators of microRNA processing complex.肿瘤抑制因子 p53、p63 和 p73 是 microRNA 加工复合物的调节因子。
PLoS One. 2010 May 12;5(5):e10615. doi: 10.1371/journal.pone.0010615.
4
The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.基因组守护者(p53、TA-p73 和 TA-p63)是肿瘤抑制 miRNA 网络的调节剂。
Cancer Metastasis Rev. 2010 Dec;29(4):613-39. doi: 10.1007/s10555-010-9257-9.
5
p63 and p73: roles in development and tumor formation.p63和p73:在发育和肿瘤形成中的作用
Mol Cancer Res. 2004 Jul;2(7):371-86.
6
The p53/p63/p73 family of transcription factors: overlapping and distinct functions.转录因子p53/p63/p73家族:重叠与独特的功能
J Cell Sci. 2000 May;113 ( Pt 10):1661-70. doi: 10.1242/jcs.113.10.1661.
7
p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.p53/p63/p73 异构体:协调细胞分化与应激反应的异构体“管弦乐队”
Cell Death Differ. 2006 Jun;13(6):962-72. doi: 10.1038/sj.cdd.4401914.
8
Therapeutic prospects for p73 and p63: rising from the shadow of p53.p73和p63的治疗前景:从p53的阴影中崛起。
Drug Resist Updat. 2008 Aug-Oct;11(4-5):152-63. doi: 10.1016/j.drup.2008.08.001. Epub 2008 Sep 17.
9
Functional interplay between MDM2, p63/p73 and mutant p53.MDM2、p63/p73与突变型p53之间的功能相互作用。
Oncogene. 2015 Aug 13;34(33):4300-10. doi: 10.1038/onc.2014.359. Epub 2014 Nov 24.
10
p63 and p73 transcriptionally regulate genes involved in DNA repair.p63 和 p73 转录调控参与 DNA 修复的基因。
PLoS Genet. 2009 Oct;5(10):e1000680. doi: 10.1371/journal.pgen.1000680. Epub 2009 Oct 9.

引用本文的文献

1
Analysis of the p53/microRNA Network in Cancer.癌症中p53/微小RNA网络的分析
Adv Exp Med Biol. 2022;1385:187-228. doi: 10.1007/978-3-031-08356-3_7.
2
Intranasal delivery of targeted polyfunctional gold-iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide.经鼻腔递送达靶性载有治疗性 microRNAs 的多功能金-氧化铁纳米颗粒用于胶质母细胞瘤的联合治疗性多模态成像和替莫唑胺预致敏
Biomaterials. 2019 Oct;218:119342. doi: 10.1016/j.biomaterials.2019.119342. Epub 2019 Jul 12.
3
Disruption of TP63-miR-27a* Feedback Loop by Mutant TP53 in Head and Neck Cancer.

本文引用的文献

1
Physical association of HDAC1 and HDAC2 with p63 mediates transcriptional repression and tumor maintenance in squamous cell carcinoma.组蛋白去乙酰化酶 1 和 2 与 p63 的物理关联介导了鳞状细胞癌中的转录抑制和肿瘤维持。
Cancer Res. 2011 Jul 1;71(13):4373-9. doi: 10.1158/0008-5472.CAN-11-0046. Epub 2011 Apr 28.
2
PARP inhibitors in cancer therapy: promise, progress, and puzzles.聚腺苷二磷酸核糖聚合酶抑制剂在癌症治疗中的应用:前景、进展与困惑。
Cancer Cell. 2011 Feb 15;19(2):165-7. doi: 10.1016/j.ccr.2011.01.047.
3
A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinoma.
头颈癌中突变型 TP53 破坏 TP63-miR-27a* 反馈环路。
J Natl Cancer Inst. 2020 Mar 1;112(3):266-277. doi: 10.1093/jnci/djz097.
4
Conditional ablation of p63 indicates that it is essential for embryonic development of the central nervous system.p63的条件性缺失表明它对中枢神经系统的胚胎发育至关重要。
Cell Cycle. 2015;14(20):3270-81. doi: 10.1080/15384101.2015.1087618.
5
Disruptive environmental chemicals and cellular mechanisms that confer resistance to cell death.具有破坏作用的环境化学物质以及赋予细胞对死亡抗性的细胞机制。
Carcinogenesis. 2015 Jun;36 Suppl 1(Suppl 1):S89-110. doi: 10.1093/carcin/bgv032.
6
Effect of microRNA-203 on tumor growth in human hypopharyngeal squamous cell carcinoma.微小RNA-203对人下咽鳞状细胞癌肿瘤生长的影响
Mol Cell Biochem. 2015 Jul;405(1-2):97-104. doi: 10.1007/s11010-015-2401-7. Epub 2015 Apr 4.
7
The microRNA feedback regulation of p63 in cancer progression.微小RNA在癌症进展中对p63的反馈调节
Oncotarget. 2015 Apr 20;6(11):8434-53. doi: 10.18632/oncotarget.3020.
8
HGF/c-Met axis drives cancer aggressiveness in the neo-adjuvant setting of ovarian cancer.在卵巢癌新辅助治疗中,肝细胞生长因子/间质上皮转化因子(HGF/c-Met)轴驱动癌症侵袭性。
Oncotarget. 2014 Jul 15;5(13):4855-67. doi: 10.18632/oncotarget.2049.
9
microRNA expression and biogenesis in cellular response to ionizing radiation.miRNA 表达与生物发生在细胞对电离辐射的反应中。
DNA Cell Biol. 2014 Oct;33(10):667-79. doi: 10.1089/dna.2014.2401. Epub 2014 Jun 6.
10
HDAC 1/4-mediated silencing of microRNA-200b promotes chemoresistance in human lung adenocarcinoma cells.组蛋白去乙酰化酶1/4介导的微小RNA-200b沉默促进人肺腺癌细胞的化疗耐药性。
Oncotarget. 2014 May 30;5(10):3333-49. doi: 10.18632/oncotarget.1948.
一种 microRNA 依赖的程序控制了人源和鼠源鳞状细胞癌中 p53 非依赖性存活和化疗敏感性。
J Clin Invest. 2011 Feb;121(2):809-20. doi: 10.1172/JCI43897.
4
Iniparib plus chemotherapy in metastatic triple-negative breast cancer.尼拉帕利联合化疗治疗转移性三阴性乳腺癌。
N Engl J Med. 2011 Jan 20;364(3):205-14. doi: 10.1056/NEJMoa1011418. Epub 2011 Jan 5.
5
TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs.TAp63 通过协调调控 Dicer 和 miRNAs 抑制转移。
Nature. 2010 Oct 21;467(7318):986-90. doi: 10.1038/nature09459.
6
The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets.核内的 PARP 侧:分子作用、生理结果和临床靶标。
Mol Cell. 2010 Jul 9;39(1):8-24. doi: 10.1016/j.molcel.2010.06.017.
7
Negative regulation of tumor suppressor p53 by microRNA miR-504.肿瘤抑制因子 p53 受 microRNA miR-504 的负调控。
Mol Cell. 2010 Jun 11;38(5):689-99. doi: 10.1016/j.molcel.2010.05.027.
8
Isoform-specific p73 knockout mice reveal a novel role for delta Np73 in the DNA damage response pathway.同种型特异性 p73 敲除小鼠揭示了 δNp73 在 DNA 损伤反应途径中的新作用。
Genes Dev. 2010 Mar 15;24(6):549-60. doi: 10.1101/gad.1873910. Epub 2010 Mar 1.
9
Regulation of p53 family member isoform DeltaNp63alpha by the nuclear factor-kappaB targeting kinase IkappaB kinase beta.p53 家族成员同工型 DeltaNp63alpha 的调节,由核因子-κB 靶向激酶 IκB 激酶β。
Cancer Res. 2010 Feb 15;70(4):1419-29. doi: 10.1158/0008-5472.CAN-09-2613. Epub 2010 Feb 9.
10
Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer.新辅助顺铂在三阴性乳腺癌中的疗效。
J Clin Oncol. 2010 Mar 1;28(7):1145-53. doi: 10.1200/JCO.2009.22.4725. Epub 2010 Jan 25.